A comparative study of brain tumor cells from different age and anatomical locations using 3D biomimetic hydrogels
Source abstract
Abstract
Brain tumors exhibit vast genotypic and phenotypic diversity depending on patient age and anatomical location. Hydrogels hold great promise as 3D in vitro models for studying brain tumor biology and drug screening, yet previous studies were limited to adult glioblastoma cells, and most studies used immortalized cell lines. Here we report a hydrogel platform that supports the proliferation and invasion of patient-derived brain tumor cell cultures (PDCs) isolated from different patient age groups and anatomical locations. Hydrogel stiffness was tuned by varying poly(ethylene-glycol) concentration. Cell adhesive peptide (CGRDS), hyaluronic acid, and MMP-cleavable crosslinkers were incorporated to facilitate cell adhesion and cell-mediated degradation. Three PDC lines were compared including adult glioblastoma cells (aGBM), pediatric glioblastoma cells (pGBM), and diffuse pontine intrinsic glioma (DIPG). A commonly used immortalized adult glioblastoma cell line U87 was included as a control. PDCs displayed stiffness-dependent behavior, with 40 Pa hydrogel promoting faster tumor proliferation and invasion. Adult GBM cells exhibited faster proliferation than pediatric GBM, and DIPG showed slowest proliferation. These results suggest both patient age and tumor location affects brain tumor behaviors. Adult GBM PDCs also exhibited very different cell proliferation and morphology from U87. The hydrogel reported here can provide a useful tool for future studies to better understand how age and anatomical locations impacts brain tumor progression using 3D in vitro models.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Cancer Cells and Metastasis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. A. B. T. Association, Types of tumors, http://www.abta.org/brain-tumor-information/types-of-tumors/, (accessed August 4, 2016).
2. A. B. T. Association, Brain tumor statistics, (accessed March 22, 2016).
3. Integrated genomic analysis identifies clinically relevant subtypes of Glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF110.1016/j.ccr.2009.12.020 ↗
4. Pediatric glioblastomas: a histopathological and molecular genetic study10.1215/15228517-2008-092 ↗
5. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients10.1159/000088731 ↗
6. The histone H3. 3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression10.1101/gad.217778.113 ↗
7. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma10.1126/science.1232245 ↗
8. Driver mutations in histone H3. 3 and chromatin remodelling genes in paediatric glioblastoma10.1038/nature10833 ↗
9. R. Spostol, I. J. Ertel, R. D. T. Jenkin, C. P. Boesel, J. L. Venes, J. A. Ortega, A. E. Evans, W. Waral and D. Hammond. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. J. Neurooncol., 7, 165-177.10.1007/BF00165101 ↗
10. Supratentorial malignant gliomas of childhood: results of treatment with radiation therapy and chemotherapy10.3171/jns.1984.60.3.0495 ↗
11. Paediatric and adult glioblastoma: multiform (epi) genomic culprits emerge10.1038/nrc3655 ↗
12. D.-F. B. Children's, Diffuse Intrinsic Pontine Glioma (DIPG), (accessed March 22, 2016).
13. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas10.1038/ng.1102 ↗
14. Diffuse brainstem glioma in children: critical review of clinical trials10.1016/S1470-2045(06)70615-5 ↗
15. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology10.1016/j.ctrv.2011.06.007 ↗
16. In vivo models of primary brain tumors: pitfalls and perspectives10.1093/neuonc/nos135 ↗
17. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro10.1038/labinvest.2013.41 ↗
18. Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia10.1038/nm.2265 ↗
19. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer10.3892/or.2015.3767 ↗
20. Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns10.1529/biophysj.105.061994 ↗
21. Impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy10.1002/jbm.a.34637 ↗
22. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform10.1016/j.biomaterials.2011.07.005 ↗
23. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells10.1016/j.biomaterials.2010.07.064 ↗
24. A synthetic modular approach for modeling the role of the 3D microenvironment in tumor progression10.1038/srep17814 ↗
25. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels10.1021/mp5000828 ↗
26. Engineering strategies to mimic the glioblastoma microenvironment10.1016/j.addr.2014.08.012 ↗
27. Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid10.1016/j.biomaterials.2013.06.024 ↗
28. Spatially gradated hydrogel platform as a 3D engineered tumor microenvironment10.1002/adma.201404896 ↗
29. Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas10.1158/1541-7786.MCR-07-0280 ↗
30. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ10.1016/j.celrep.2012.12.013 ↗
31. Matrix elasticity directs stem cell lineage specification10.1016/j.cell.2006.06.044 ↗
32. Time course of tissue elasticity and fluidity in vasogenic brain edema
33. Glioma invasion: mechanisms and therapeutic challenges
34. Malignant glioma: genetics and biology of a grave matter10.1101/gad.891601 ↗
35. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts
36. Structural alterations of the epidermal growth factor receptor gene in human gliomas10.1073/pnas.89.7.2965 ↗
37. Neuronal activity promotes glioma growth through neuroligin-3 secretion10.1016/j.cell.2015.04.012 ↗
38. A versatile synthetic extracellular matrix mimic via thiol-norbornene photopolymerization10.1002/adma.200901808 ↗
39. Disulfide cross-linked hyaluronan hydrogels10.1021/bm025603c ↗
40. The performance of human mesenchymal stem cells encapsulated in cell-degradable polymer-peptide hydrogels10.1016/j.biomaterials.2011.01.064 ↗
41. Matrix stiffness modulates patient-derived glioblastoma cell fates in 3D hydrogels
42. Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma10.1016/S0959-8049(05)80214-X ↗
43. Subventricular spread of diffuse intrinsic pontine glioma10.1007/s00401-014-1307-x ↗
44. Mechanical integration of actin and adhesion dynamics in cell migration10.1146/annurev.cellbio.011209.122036 ↗
45. The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells10.1158/0008-5472.CAN-08-4859 ↗
46. Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches10.3892/ol.2016.4952 ↗
47. Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas
48. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort
49. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas10.1097/PAS.0b013e318294e817 ↗
50. Brain tumour cells interconnect to a functional and resistant network10.1038/nature16071 ↗
51. Inhibition of pediatric glioblastoma tumor growth by the anti-cancer agent OKN-007 in orthotopic mouse Xenografts10.1371/journal.pone.0134276 ↗
52. Human pontine glioma cells can induce murine tumors10.1007/s00401-014-1272-4 ↗